Yousif Capital Management LLC Sells 232 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Yousif Capital Management LLC trimmed its position in ICU Medical, Inc. (NASDAQ:ICUI) by 2.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,213 shares of the medical instruments supplier’s stock after selling 232 shares during the period. Yousif Capital Management LLC’s holdings in ICU Medical were worth $1,279,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd purchased a new stake in shares of ICU Medical in the fourth quarter worth approximately $33,000. Quarry LP raised its position in ICU Medical by 764.3% in the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 214 shares during the last quarter. Murphy & Mullick Capital Management Corp purchased a new stake in ICU Medical in the 4th quarter valued at $52,000. Venturi Wealth Management LLC raised its position in ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock valued at $82,000 after buying an additional 206 shares during the last quarter. Finally, Russell Investments Group Ltd. raised its position in ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock valued at $99,000 after buying an additional 300 shares during the last quarter. 96.10% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, COO Christian B. Voigtlander sold 4,985 shares of ICU Medical stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $128.50, for a total value of $640,572.50. Following the completion of the sale, the chief operating officer now owns 6,088 shares of the company’s stock, valued at approximately $782,308. This trade represents a 45.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 600 shares of ICU Medical stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $138.92, for a total transaction of $83,352.00. Following the completion of the transaction, the director now owns 3,252 shares of the company’s stock, valued at $451,767.84. The trade was a 15.58% decrease in their position. The disclosure for this sale can be found here. Insiders sold 36,097 shares of company stock valued at $4,860,156 over the last ninety days. 1.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. Wall Street Zen upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Sunday, May 18th. Raymond James Financial decreased their price objective on shares of ICU Medical from $197.00 to $187.00 and set a “strong-buy” rating for the company in a research note on Friday, May 9th. Finally, KeyCorp decreased their price target on ICU Medical from $209.00 to $191.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $192.67.

ICU Medical Trading Down 2.5%

Shares of ICU Medical stock opened at $129.97 on Wednesday. ICU Medical, Inc. has a 1 year low of $111.97 and a 1 year high of $196.26. The stock has a fifty day moving average price of $135.90 and a 200-day moving average price of $148.17. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.59 and a quick ratio of 1.52. The firm has a market cap of $3.20 billion, a PE ratio of -33.93 and a beta of 0.88.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.23 by $0.49. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The business had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. During the same quarter last year, the company posted $0.96 earnings per share. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. Equities research analysts anticipate that ICU Medical, Inc. will post 4.11 EPS for the current year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.